Bremelanotide acetate is a compound with a cyclic heptapeptide structure. A large number of studies have shown that its receptor molecules play an important role in sexual arousal, appetite reduction and catalytic melanin synthesis. Therefore, it can be used to treat sexual dysfunction, obesity, and promote skin melanin production to resist ultraviolet burn and other related diseases. PT-141 is a drug developed by Palatin company of the United States for the treatment of sexual dysfunction. At present, it has completed phase III clinical trials. The results show that PT-141 is effective for both men and women, especially for women with sexual apathy.
Basic Information
English name: 醋酸布雷默浪丹
Company number: GT-A005
CAS number: 189691-06-3, 1607799-13-2 (Acetate)
Sequence: Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-OH (amide ring Asp2-Lys7)
Molecular formula: C50H68N14O10
Molecular weight: 1025.16
Post time: Mar-31-2025